| Journal | Autism research : official journal of the International Society for Autism Research |
| Study Type | Randomized Trial |
| Population | Human participants |
This is the first rigorous randomized controlled crossover trial examining CBD’s effects on core autism symptoms in children, addressing a critical evidence gap where families are already using cannabis products with limited clinical guidance. The study provides much-needed data on whether CBD can meaningfully impact social functioning and behavioral outcomes that are central to autism spectrum disorder.
Twenty-nine autistic children aged 5-12 received 10 mg/kg/day of CBD oil or placebo in a 12-week crossover design with 8-week washout. The primary outcome (Social Responsiveness Scale-2) showed no significant improvement with CBD treatment. Secondary measures of social relating, anxiety, sleep, developmental behaviors, and parental stress also failed to demonstrate clinically meaningful benefits over placebo. The crossover design strengthens validity by having each child serve as their own control, though the sample size remains modest for detecting smaller effect sizes.
“I’m not surprised by these null findings – the evidence base for CBD in neurodevelopmental conditions has been largely anecdotal, and this study appropriately challenges those assumptions with rigorous methodology. This reinforces my clinical approach of emphasizing behavioral interventions and evidence-based therapies as first-line treatments for autism symptoms.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Does CBD oil improve core autism symptoms in children?
- What dosage of CBD was tested for autism in children?
- How long does it take to see potential effects of CBD in autistic children?
- Did CBD reduce anxiety or parental stress in families with autistic children?
- Is CBD oil safe for children with autism spectrum disorder?
FAQ
Does CBD oil improve core autism symptoms in children?
This randomized controlled trial found no significant improvement in the primary outcome measure (Social Responsiveness Scale-2) for core autism symptoms. The study used 10 mg/kg/day of CBD oil with terpenes over 12-week periods in 29 children aged 5-12 years.
What dosage of CBD was tested for autism in children?
The study used weight-based dosing of 10 mg/kg/day of CBD oil containing terpenes. This dosage was administered orally over two 12-week intervention periods in a crossover design with an 8-week washout period between treatments.
How long does it take to see potential effects of CBD in autistic children?
The study design included 12-week treatment periods, suggesting this timeframe is necessary to evaluate CBD’s effects. An 8-week washout period was used between treatments to ensure complete elimination of the compound before crossover.
Did CBD reduce anxiety or parental stress in families with autistic children?
While the study measured anxiety (PROMIS Anxiety scale) and parental stress (Autism Parenting Stress Index) as secondary outcomes, the provided summary does not report specific results for these measures. The primary social responsiveness outcome showed no significant improvement.
Is CBD oil safe for children with autism spectrum disorder?
The study was completed by all 29 enrolled children, suggesting good tolerability, but specific safety data are not detailed in this summary. The crossover design with washout periods indicates researchers took precautions to monitor for adverse effects and drug interactions.